{"id":"https://openalex.org/W2055495993","doi":"https://doi.org/10.1192/bjp.bp.105.011015","title":"Antidepressant therapy and C-reactive protein levels","display_name":"Antidepressant therapy and C-reactive protein levels","alternate_titles":[],"publication_year":2006,"publication_date":"2006-04-28","ids":{"openalex":"https://openalex.org/W2055495993","doi":"https://doi.org/10.1192/bjp.bp.105.011015","mag":"2055495993","pmid":"https://pubmed.ncbi.nlm.nih.gov/16648531"},"language":"en","primary_location":{"id":"doi:10.1192/bjp.bp.105.011015","doi":"https://doi.org/10.1192/bjp.bp.105.011015","is_oa":true,"landing_page_url":"https://doi.org/10.1192/bjp.bp.105.011015","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/5465AFB8673C4B22AA64241B99C4B2B9/S0007125000231553a.pdf/div-class-title-antidepressant-therapy-and-c-reactive-protein-levels-div.pdf","source":{"id":"https://openalex.org/S127936299","display_name":"The British Journal of Psychiatry","issn_l":"0007-1250","issn":["0007-1250","1472-1465"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Psychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2055495993"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/5465AFB8673C4B22AA64241B99C4B2B9/S0007125000231553a.pdf/div-class-title-antidepressant-therapy-and-c-reactive-protein-levels-div.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103407894","display_name":"Sinead M. O\u2019Brien","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I27577105","display_name":"University College Cork","ror":"https://ror.org/03265fv13","country_code":"IE","type":"education","lineage":["https://openalex.org/I27577105"]}],"countries":["IE"],"is_corresponding":false,"raw_author_name":"Sinead M. O'Brien","raw_affiliation_strings":["Department of Psychiatry and Alimentary Pharmabiotic Centre, University College Cork, Cork, Ireland","Department of Psychiatry and Alimentary Pharmabiotic Centre, University College Cork, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Alimentary Pharmabiotic Centre, University College Cork, Cork, Ireland","institution_ids":["https://openalex.org/I27577105"]},{"raw_affiliation_string":"Department of Psychiatry and Alimentary Pharmabiotic Centre, University College Cork, Ireland","institution_ids":["https://openalex.org/I27577105"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111802461","display_name":"Lucinda V. Scott","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I27577105","display_name":"University College Cork","ror":"https://ror.org/03265fv13","country_code":"IE","type":"education","lineage":["https://openalex.org/I27577105"]}],"countries":["IE"],"is_corresponding":false,"raw_author_name":"Lucinda V. Scott","raw_affiliation_strings":["Department of Psychiatry and Alimentary Pharmabiotic Centre, University College Cork, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Alimentary Pharmabiotic Centre, University College Cork, Ireland","institution_ids":["https://openalex.org/I27577105"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087830456","display_name":"Timothy G. Dinan","orcid":"https://orcid.org/0000-0002-2316-7220","observed_orcids":["https://orcid.org/0000-0002-2316-7220"]},"institutions":[{"id":"https://openalex.org/I27577105","display_name":"University College Cork","ror":"https://ror.org/03265fv13","country_code":"IE","type":"education","lineage":["https://openalex.org/I27577105"]}],"countries":["IE"],"is_corresponding":true,"raw_author_name":"Timothy G. Dinan","raw_affiliation_strings":["Department of Psychiatry and Alimentary Pharmabiotic Centre, University College Cork, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Alimentary Pharmabiotic Centre, University College Cork, Ireland","institution_ids":["https://openalex.org/I27577105"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5087830456"],"corresponding_institution_ids":["https://openalex.org/I27577105"],"apc_list":{"value":4920,"currency":"USD","value_usd":4920},"apc_paid":null,"fwci":3.1138,"has_fulltext":true,"cited_by_count":163,"citation_normalized_percentile":{"value":0.92941176,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"188","issue":"5","first_page":"449","last_page":"452"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11337","display_name":"Tryptophan and brain disorders","score":0.8604000210762024,"subfield":{"id":"https://openalex.org/subfields/2803","display_name":"Biological Psychiatry"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11337","display_name":"Tryptophan and brain disorders","score":0.8604000210762024,"subfield":{"id":"https://openalex.org/subfields/2803","display_name":"Biological Psychiatry"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.13670000433921814,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10529","display_name":"Stress Responses and Cortisol","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/2802","display_name":"Behavioral Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/c-reactive-protein","display_name":"C-reactive protein","score":0.9679999947547913},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.9520000219345093},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.9769999980926514},{"id":"https://openalex.org/keywords/antidepressant-treatment","display_name":"antidepressant treatment","score":0.8769999742507935},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.7170000076293945}],"concepts":[{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.8050252199172974},{"id":"https://openalex.org/C2780092697","wikidata":"https://www.wikidata.org/wiki/Q7455053","display_name":"Serotonin reuptake inhibitor","level":4,"score":0.7132426500320435},{"id":"https://openalex.org/C2781195455","wikidata":"https://www.wikidata.org/wiki/Q422766","display_name":"C-reactive protein","level":3,"score":0.693196177482605},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.6806463003158569},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5655002593994141},{"id":"https://openalex.org/C31487548","wikidata":"https://www.wikidata.org/wiki/Q4859664","display_name":"Reuptake inhibitor","level":4,"score":0.5226325988769531},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.5213093161582947},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.44130077958106995},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.4332926273345947},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3797500729560852},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.2095767855644226},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.10032737255096436},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C2779144063","wikidata":"https://www.wikidata.org/wiki/Q338924","display_name":"Amygdala","level":2,"score":0.0},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002097","descriptor_name":"C-Reactive Protein","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005473","descriptor_name":"Fluoxetine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017374","descriptor_name":"Paroxetine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D020280","descriptor_name":"Sertraline","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1192/bjp.bp.105.011015","doi":"https://doi.org/10.1192/bjp.bp.105.011015","is_oa":true,"landing_page_url":"https://doi.org/10.1192/bjp.bp.105.011015","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/5465AFB8673C4B22AA64241B99C4B2B9/S0007125000231553a.pdf/div-class-title-antidepressant-therapy-and-c-reactive-protein-levels-div.pdf","source":{"id":"https://openalex.org/S127936299","display_name":"The British Journal of Psychiatry","issn_l":"0007-1250","issn":["0007-1250","1472-1465"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Psychiatry","raw_type":"journal-article"},{"id":"pmid:16648531","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16648531","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The British journal of psychiatry : the journal of mental science","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1192/bjp.bp.105.011015","doi":"https://doi.org/10.1192/bjp.bp.105.011015","is_oa":true,"landing_page_url":"https://doi.org/10.1192/bjp.bp.105.011015","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/5465AFB8673C4B22AA64241B99C4B2B9/S0007125000231553a.pdf/div-class-title-antidepressant-therapy-and-c-reactive-protein-levels-div.pdf","source":{"id":"https://openalex.org/S127936299","display_name":"The British Journal of Psychiatry","issn_l":"0007-1250","issn":["0007-1250","1472-1465"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Psychiatry","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320311904","display_name":"Wellcome Trust","ror":"https://ror.org/029chgv08"},{"id":"https://openalex.org/F4320312041","display_name":"Health Research Board","ror":"https://ror.org/003hb2249"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2055495993.pdf","grobid_xml":"https://content.openalex.org/works/W2055495993.grobid-xml"},"referenced_works_count":23,"referenced_works":["https://openalex.org/W109431680","https://openalex.org/W2011092724","https://openalex.org/W2024886564","https://openalex.org/W2038473038","https://openalex.org/W2044508901","https://openalex.org/W2048876068","https://openalex.org/W2055476558","https://openalex.org/W2058610272","https://openalex.org/W2058709767","https://openalex.org/W2065054942","https://openalex.org/W2068270366","https://openalex.org/W2075840772","https://openalex.org/W2079522334","https://openalex.org/W2090851364","https://openalex.org/W2102899779","https://openalex.org/W2110969697","https://openalex.org/W2114613490","https://openalex.org/W2120549911","https://openalex.org/W2148322270","https://openalex.org/W2156139207","https://openalex.org/W2159011576","https://openalex.org/W2159087408","https://openalex.org/W2168699761"],"related_works":["https://openalex.org/W7171989366","https://openalex.org/W2920331744","https://openalex.org/W7064925744","https://openalex.org/W4396878532","https://openalex.org/W2090213741","https://openalex.org/W4382280346","https://openalex.org/W2582188919","https://openalex.org/W175579013","https://openalex.org/W7143470697"],"abstract_inverted_index":{"BACKGROUND:":[0],"Major":[1],"depression":[2,18,94,148,162],"is":[3,150],"associated":[4],"with":[5,55,67,92,114,123,139],"activation":[6],"of":[7,24,58,63,174],"the":[8,22,112,126,132,161],"inflammatory":[9],"response.":[10],"AIMS:":[11],"To":[12],"examine":[13],"C-reactive":[14,43,85,105,155],"protein":[15,44,86,106,133,156],"levels":[16,107,134],"in":[17,47,71,89,154],"and":[19,70,97,125],"to":[20],"determine":[21],"impact":[23],"selective":[25],"serotonin":[26],"reuptake":[27],"inhibitor":[28],"(SSRI)":[29],"therapy.":[30],"METHOD:":[31],"A":[32],"two-part":[33],"study.":[34],"In":[35,102,129],"study":[36,103,130],"1,":[37,104],"which":[38],"used":[39],"a":[40,56,72,82,151],"between-subjects":[41],"design,":[42],"was":[45,87],"measured":[46,88],"32":[48],"patients":[49,91],"(20":[50],"currently":[51,118],"depressed,":[52],"12":[53],"euthymic)":[54,121],"history":[57],"DSM-IV":[59],"major":[60,93,147],"depression,":[61],"all":[62],"whom":[64],"were":[65],"treated":[66,122],"an":[68,170],"SSRI,":[69],"healthy":[73,127],"comparison":[74],"group":[75,113],"(n":[76],"=":[77],"20).":[78],"Study":[79],"2":[80,131],"employed":[81],"within-subject":[83],"design:":[84],"20":[90],"both":[95],"before":[96],"after":[98],"SSRI":[99,144],"treatment.":[100],"RESULTS:":[101],"did":[108],"not":[109,160],"differ":[110],"between":[111],"depressive":[115],"disorder":[116],"(either":[117],"depressed":[119],"or":[120,159],"SSRIs":[124],"group.":[128],"dropped":[135],"significantly":[136],"following":[137],"treatment":[138,145],"antidepressant":[140,175],"medication.":[141],"CONCLUSIONS:":[142],"Following":[143],"for":[146],"there":[149],"significant":[152],"drop":[153],"concentrations":[157],"whether":[158],"resolves.":[163],"These":[164],"findings":[165],"indicate":[166],"that":[167],"antidepressants":[168],"induce":[169],"anti-inflammatory":[171],"response":[172],"independent":[173],"action.":[176]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2055495993","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":11},{"year":2016,"cited_by_count":20},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":9},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
